Ad is loading...
LGND
Price
$124.19
Change
+$0.68 (+0.55%)
Updated
Dec 6, 04:59 PM (EDT)
60 days until earnings call
VKTX
Price
$50.77
Change
+$0.89 (+1.78%)
Updated
Dec 6, 04:59 PM (EDT)
59 days until earnings call
Ad is loading...

LGND vs VKTX

Header iconLGND vs VKTX Comparison
Open Charts LGND vs VKTXBanner chart's image
Ligand Pharmaceuticals
Price$124.19
Change+$0.68 (+0.55%)
Volume$1K
CapitalizationN/A
Viking Therapeutics
Price$50.77
Change+$0.89 (+1.78%)
Volume$25.28K
CapitalizationN/A
LGND vs VKTX Comparison Chart
Loading...
LGND
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
LGND vs. VKTX commentary
Dec 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGND is a Buy and VKTX is a StrongBuy.

COMPARISON
Comparison
Dec 08, 2024
Stock price -- (LGND: $124.83 vs. VKTX: $50.80)
Brand notoriety: LGND and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGND: 107% vs. VKTX: 59%
Market capitalization -- LGND: $2.33B vs. VKTX: $5.56B
LGND [@Biotechnology] is valued at $2.33B. VKTX’s [@Biotechnology] market capitalization is $5.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGND’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • LGND’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than LGND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGND’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • LGND’s TA Score: 4 bullish, 4 bearish.
  • VKTX’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, LGND is a better buy in the short-term than VKTX.

Price Growth

LGND (@Biotechnology) experienced а +2.77% price change this week, while VKTX (@Biotechnology) price change was -4.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

LGND is expected to report earnings on Feb 06, 2025.

VKTX is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($5.56B) has a higher market cap than LGND($2.33B). VKTX YTD gains are higher at: 172.972 vs. LGND (74.783). LGND has higher annual earnings (EBITDA): 95.8M vs. VKTX (-133.66M). VKTX has more cash in the bank: 930M vs. LGND (220M). VKTX has less debt than LGND: VKTX (1.24M) vs LGND (7.36M). LGND has higher revenues than VKTX: LGND (152M) vs VKTX (0).
LGNDVKTXLGND / VKTX
Capitalization2.33B5.56B42%
EBITDA95.8M-133.66M-72%
Gain YTD74.783172.97243%
P/E Ratio49.60N/A-
Revenue152M0-
Total Cash220M930M24%
Total Debt7.36M1.24M596%
FUNDAMENTALS RATINGS
LGND vs VKTX: Fundamental Ratings
LGND
VKTX
OUTLOOK RATING
1..100
9310
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
4938
SMR RATING
1..100
8091
PRICE GROWTH RATING
1..100
3847
P/E GROWTH RATING
1..100
83100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (56) in the Biotechnology industry is in the same range as LGND (77). This means that VKTX’s stock grew similarly to LGND’s over the last 12 months.

VKTX's Profit vs Risk Rating (38) in the Biotechnology industry is in the same range as LGND (49). This means that VKTX’s stock grew similarly to LGND’s over the last 12 months.

LGND's SMR Rating (80) in the Biotechnology industry is in the same range as VKTX (91). This means that LGND’s stock grew similarly to VKTX’s over the last 12 months.

LGND's Price Growth Rating (38) in the Biotechnology industry is in the same range as VKTX (47). This means that LGND’s stock grew similarly to VKTX’s over the last 12 months.

LGND's P/E Growth Rating (83) in the Biotechnology industry is in the same range as VKTX (100). This means that LGND’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LGNDVKTX
RSI
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
75%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
LGND
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QJUN28.450.15
+0.53%
FT Cboe Vest Nasdaq-100 Buffer ETF - Jun
EMNT98.630.03
+0.03%
PIMCO Enhanced Short Mtrty Actv ESG ETF
XVOL24.09N/A
N/A
Acruence Active Hedge US Equity ETF
FFIU22.19-0.07
-0.31%
Fieldstone UVA Uncons Md-Trm Fxd Inc ETF
IFRA50.27-0.42
-0.83%
iShares US Infrastructure ETF

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with DNLI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
+1.07%
DNLI - LGND
54%
Loosely correlated
+6.73%
AXON - LGND
49%
Loosely correlated
-0.30%
VKTX - LGND
45%
Loosely correlated
+1.84%
JANX - LGND
44%
Loosely correlated
-1.98%
VCYT - LGND
41%
Loosely correlated
+3.01%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with JANX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then JANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+1.84%
JANX - VKTX
64%
Loosely correlated
-1.98%
DNLI - VKTX
46%
Loosely correlated
+6.73%
LGND - VKTX
45%
Loosely correlated
+1.07%
ALT - VKTX
40%
Loosely correlated
-0.33%
AKRO - VKTX
39%
Loosely correlated
+4.75%
More